Neoadjuvant Atezolizumab in Localized Bladder Cancer

Clinical trial NCT02451423 · COMPLETED

Trial details

NCT number: NCT02451423
Sponsor: Lawrence Fong
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Transitional Cell

Start date: 2016-03-29
Primary completion: 2023-03-31
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.